Predicting the clinical outcome of melanoma using an immune-related gene pairs signature
Fig 5
The relative fraction of infiltrated immune cells in different risk groups in the TCGA dataset.
(A) Radar plot of the difference in the abundance of 22 immune cells in tumor tissue in the two risk groups. (B) Violin plot of differences in various immune cell abundances between the high- and low-risk groups. (*FDR adjusted P-value<0.05, **FDR adjusted P-value <0.01, ***FDR adjusted P-value<0.001).